When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Musical hallucinations - Wikipedia

   en.wikipedia.org/wiki/Musical_hallucinations

   Donepezil, which belongs to a class of medication called acetylcholinesterase inhibitors, is most commonly used to treat dementia in patients with Alzheimer's disease. Although it cannot cure Alzheimer's, it can provide patients with a better quality of life by inhibiting the loss of function and improving the ability to think. [ 20 ]

3. Doctors Say This Nighttime Behavior Can Be A Sign Of Dementia

   www.aol.com/lifestyle/doctors-nighttime-behavior...

   Here's how to distinguish "sundowning"—agitation or confusion later in the day in dementia patients—from typical aging, from doctors who treat older adults. ... Hallucinations.

4. Dementia with Lewy bodies - Wikipedia

   en.wikipedia.org/wiki/Dementia_with_Lewy_bodies

   Dementia with Lewy bodies (DLB) is a type of dementia, a group of diseases involving progressive neurodegeneration of the central nervous system. [11] It is one of the two Lewy body dementias, along with Parkinson's disease dementia. [12] Dementia with Lewy bodies can be classified in other ways.

5. Dementia - Wikipedia

   en.wikipedia.org/wiki/Dementia

   Diagnosis of mixed dementia can be difficult, as often only one type will predominate. This makes the treatment of people with mixed dementia uncommon, with many people missing out on potentially helpful treatments. Mixed dementia can mean that symptoms onset earlier, and worsen more quickly since more parts of the brain will be affected. [15]

6. What is Lewy body dementia? - AOL

   www.aol.com/lifestyle/jack-russell-great-white...

   Lewy body dementia symptoms. Lewy body dementia can cause various symptoms that may impact a person’s cognition, movement, sleep and behavior. According to the NIA, those can include: Hallucinations

7. Acadia to stop trials of antipsychotic drug after it fails ...

   www.aol.com/news/acadia-pharmaceuticals...

   The decision comes after two failed attempts to secure regulatory approval for the expanded use of pimavanserin in the treatment of psychosis related to dementia and Alzheimer's disease in 2021 ...